Gene · 3594
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Methylome of Different Forms of Basal Cell Hyperplasia and Squamous Cell Metaplasia of Bronchial Epithelium. | Bull Exp Biol Med | 2024 | 38963595 | PubTator, text mining | PubMed |
| A predictive study of genes related to lactic acid metabolism in cervical carcinoma. | J Obstet Gynaecol Res | 2024 | 38923668 | PubTator, text mining | PubMed |
| Multi-omics and multi-stages integration identified a novel variant associated with silicosis risk. | Arch Toxicol | 2024 | 38811393 | PubTator, text mining | PubMed |
| Salmonella Pneumonia in a Patient with Inherited IL-12Rβ1 Deficiency. | J Clin Immunol | 2024 | 38775893 | PubTator, text mining | PubMed |
| The IL-21/IL-21R signaling axis regulates CD4+ T-cell responsiveness to IL-12 to promote bacterial-induced colitis. | J Leukoc Biol | 2024 | 38498592 | PubTator, text mining | PubMed |
| Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review. | J Allergy Clin Immunol | 2024 | 38341181 | PubTator, text mining | PubMed |
| Discovering the link between IL12RB1 gene polymorphisms and tuberculosis susceptibility: a comprehensive meta-analysis. | Front Public Health | 2024 | 38317798 | PubTator, text mining | PubMed |
| Consanguineous marriages increase the incidence of recurrent tuberculosis: Evidence from whole exome sequencing. | Infect Genet Evol | 2024 | 38266757 | PubTator, text mining | PubMed |
| Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study. | EClinicalMedicine | 2024 | 38261958 | PubTator, text mining | PubMed |
| Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review. | Biomedicines | 2024 | 38255237 | PubTator, text mining | PubMed |
| Breakthrough of solid tumor treatment: CAR-NK immunotherapy. | Cell Death Discov | 2024 | 38245520 | PubTator, text mining | PubMed |
| Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model. | Cell Death Dis | 2024 | 38195589 | PubTator, text mining | PubMed |
Modulation of mitochondrial activity by sugarcane (Saccharum officinarum L.) top extract and its bioactive polyphenols: a comprehensive transcriptomics analysis in C2C12 myotubes and HepG2 hepatocytes. | Nat Prod Bioprospect | 2024 | 38177614 | PubTator, text mining | PubMed |
| Manganese and IL-12 treatment alters the ovarian tumor microenvironment. | Aging (Albany NY) | 2024 | 38175694 | PubTator, text mining | PubMed |
| Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis. | Int J Biol Sci | 2024 | 38169676 | PubTator, text mining | PubMed |
| IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity. | Nat Commun | 2024 | 38167707 | PubTator, text mining | PubMed |
| Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials. | Cancer Res Commun | 2024 | 38108458 | PubTator, text mining | PubMed |
| Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review. | Pathogens | 2023 | 38276158 | PubTator, text mining | PubMed |
| Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine. | Front Oncol | 2023 | 38260854 | PubTator, text mining | PubMed |
| Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets. | Front Immunol | 2023 | 38239345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3594/papers?page=5